XML 50 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Summary of restricted stock and restricted stock units activity
The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2019:

Number
of Shares
Weighted
Average Grant
Price and Fair Value
Non vested, December 31, 2018490,342 $24.23 
Shares granted333,635 29.48 
Vested shares(255,918)22.98 
Shares forfeited(21,119)26.86 
Non vested, December 31, 2019546,940 $27.81 

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2020:
Number
of Shares
Weighted
Average Grant
Price and Fair Value
Non vested, December 31, 2019546,940 $27.81 
Shares granted396,976 24.94 
Vested shares(307,937)26.95 
Shares forfeited(109,179)26.56 
Non vested, December 31, 2020526,800 $26.43 

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2021:
Number
of Shares
Weighted
Average Grant
Price and Fair Value
Non vested, December 31, 2020
526,800 $26.43 
Shares granted343,851 29.50 
Vested shares(268,329)26.66 
Shares forfeited(95,535)28.78 
Non vested, December 31, 2021
506,787 $27.68 
Summary of status of stock incentive plans and changes during periods
The table below sets forth stock option activity for the year ended December 31, 2019:
Number
of Options
Weighted
Average Exercise
Price
Weighted
Average
Contractual
Life (years)
Aggregate
Intrinsic
Value
   (in thousands)
Outstanding, December 31, 2018— $— 
Options granted43,134 23.77 10
Awards exercised— — 
Options forfeited— — 
Outstanding, December 31, 201943,134 $23.77 9.73$156 
Exercisable, December 31, 2019— $— $— 

The table below sets forth stock option activity for the year ended December 31, 2020:
Number
of Options
Weighted
Average Exercise
Price
Weighted
Average
Contractual
Life (years)
Aggregate
Intrinsic
Value
   (in thousands)
Outstanding, December 31, 201943,134 $23.77 9.73$156 
Options granted17,370 33.11 10$— 
Awards exercised— — 
Options forfeited— — 
Outstanding, December 31, 202060,504 $26.45 8.96$264 
Exercisable, December 31, 202014,378 $23.77 8.73$88 
The table below sets forth stock option activity for the year ended December 31, 2021:
Number
of Options
Weighted
Average Exercise
Price
Weighted
Average
Contractual
Life (years)
Aggregate
Intrinsic
Value
   (in thousands)
Outstanding, December 31, 202060,504 $26.45 8.96$264 
Options granted51,230 27.72 10$— 
Awards exercised— —   
Options forfeited(10,214)30.83   
Outstanding, December 31, 2021101,520 $26.65 8.39$— 
Exercisable, December 31, 202134,547 $25.34 7.10$— 
Summary of fair value at the date of grant
The following table sets forth the assumptions used in calculating the fair value at the date of grant of each option award granted:
Year Ended December 31,
 201920202021
Expected volatility47.37 %48.74 %44.18 %
Expected dividends— %— %— %
Expected term, in years101010
Risk-free interest rate1.74 %0.68 %1.35 %
Weighted-average fair value of options granted during the year$13.91 $18.99 $15.13 
Summary of stock-based compensation
For the years ended December 31, 2019, 2020, and 2021, the Company recognized stock-based compensation expense as follows:
 Year Ended December 31,
 201920202021
 (In thousands)
Instructional costs and services$1,570 $1,535 $1,480 
Selling and promotional766 1,007 771 
General and administrative3,624 4,533 5,403 
Total stock-based compensation expense$5,960 $7,075 $7,654